Expansion of leadership team with deep translational oncology drug development expertise as Company prepares for clinical development of lead programs CAMBRIDGE, Mass., Nov. 9, 2020 /PRNewswire/ -- Werewolf Therapeutics, Inc., an oncology biotherapeutics company developing next-generation,

CAMBRIDGE, Mass., Aug. 10, 2020 /PRNewswire/ -- Werewolf Therapeutics, Inc., an oncology biotherapeutics company developing next-generation, transformative cancer therapeutics, today announced the appointment of Ellen Lubman to the company's newly created position of Chief Business Officer.

Designing conditionally activated therapeutics that unleash a powerful attack on cancer cells Company led by experienced team with proven track record of developing novel medicines for the treatment of cancer CAMBRIDGE, Mass., Nov. 20, 2019 /PRNewswire/ -- Werewolf Therapeutics, an oncology